Surveillance of High - Risk Group May Downstage Pancreatic Cancer

For patients with screen - detected PDAC, median survival was 9.8 years versus 1.5 for those with PDAC detected outside of surveillance
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Journal, Source Type: news